All In Biotech

Drug Trial Radar · NCT04408794

Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

A Phase 2/3 Open-label, Long-Term, Safety Trial of BHV3500 (Zavegepant*) Intranasal (IN) for the Acute Treatment of Migraine

Last checked: Nov 20, 2026Latest source record: May 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

974

Actual

Start

Jun 29, 2020

Primary completion

Dec 9, 2021

Study completion Dec 23, 2021

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 29, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety of BHV-3500/vazegepant intranasal in the acute treatment of migraine. \* BHV-3500, formerly "vazegepant", is now referred to as "zavegepant" (za ve' je pant). The World Health Organization (WHO) International Nonproprietary Names (INN) Expert Committee revised the name to "zavegepant" which was accepted by the United States Adopted Names (USAN ) Council for use in the U.S. and is pending formal adoption by the INN for international use.

Conditions

  • Acute Migraine

Interventions

  • Zavegepant (BHV-3500)Drug

    10 mg IN up to 8 times per month, up to 1 year

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number Of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and AEs Leading To DiscontinuationTime frame: From study drug dosing up to the end of the study (up to 52 weeks)
  2. Number Of Participants With Clinically Significant Laboratory AbnormalitiesTime frame: From study drug dosing up to the end of the study (up to 52 weeks)

Locations

67 sites in 1 country. Site status is shown where the registry gives one.

  • Medical Affiliated Research Center

    Huntsville, Alabama

  • Coastal Clinical Research, LLC, An AMR Co.

    Mobile, Alabama

  • Tucson Neuroscience Research

    Tucson, Arizona

  • Baptist Health Center for Clinical Research

    Little Rock, Arkansas

  • Pharmacology Research Institute

    Encino, California

  • eStudySite

    La Mesa, California

  • Synergy San Diego

    Lemon Grove, California

  • Collaborative Neuroscience Network, LLC

    Long Beach, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • Wr-Pri, Llc

    Newport Beach, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Artemis Institute for Clinical Research

    San Marcos, California

  • California Medical Clinic for Headache

    Santa Monica, California

  • California Neuroscience Research Medical Group, Inc.

    Sherman Oaks, California

  • CT Clinical Research

    Cromwell, Connecticut

  • Ki Health Partners, LLC dba New England Institute for Clinical Research

    Stamford, Connecticut

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Multi-Specialty Research Associates, Inc.

    Lake City, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Ormond Medical Arts Pharmaceutical Research Center

    Ormond Beach, Florida

  • Meridien Research

    Tampa, Florida

  • iResearch Atlanta, LLC

    Decatur, Georgia

  • Meridian Clinical Research, LLC

    Savannah, Georgia

  • Northwest Clinical Trials Inc.

    Boise, Idaho

  • Community Hospital of Anderson and Madison County Inc

    Anderson, Indiana

  • Fort Wayne Neurological Center

    Fort Wayne, Indiana

  • Collective Medical Research

    Prairie Village, Kansas

  • Crescent City Headache and Neurology Center

    Chalmette, Louisiana

  • Boston Clinical Trials

    Boston, Massachusetts

  • Community Clinical Research Network

    Marlborough, Massachusetts

  • Boston Neuro Research Center

    South Dartmouth, Massachusetts

  • Medvadis Research Corporation

    Waltham, Massachusetts

  • Michigan Headache and Neurological Institute

    Ann Arbor, Michigan

  • Clinical Research Institute, Inc.

    Minneapolis, Minnesota

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Clinvest Research LLC

    Springfield, Missouri

  • Sundance Clinical Research, LLC

    St Louis, Missouri

  • Dartmouth-Hitchcock Heater Road

    Lebanon, New Hampshire

  • Albuquerque Clinical Trials, Inc.

    Albuquerque, New Mexico

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.